Review Article
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin
Table 2
Selected clinical trials of cytotoxic chemotherapy in advanced PNET**.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
**Several of the early studies often assessed tumor response and PFS by clinical and not imaging parameters. PFS: progression-free survival, STZ: streptozocin, 5FU: 5-flurouracil, DOX: doxorubicin, DTIC: dacarbazine, TMZ: temozolomide, NR: not reported. |